Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Memory T Cells Constitute a Subset of the Human CD8+CD45RA+ Pool with Distinct Phenotypic and Migratory Characteristics

Jeffery M. Faint, Nicola E. Annels, S. John Curnow, Philip Shields, Darrell Pilling, Andrew D. Hislop, Lijun Wu, Arne N. Akbar, Christopher D. Buckley, Paul A. H. Moss, David H. Adams, Alan B. Rickinson and Mike Salmon
J Immunol July 1, 2001, 167 (1) 212-220; DOI: https://doi.org/10.4049/jimmunol.167.1.212
Jeffery M. Faint
*University of Birmingham/Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicola E. Annels
*University of Birmingham/Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. John Curnow
*University of Birmingham/Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Shields
*University of Birmingham/Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darrell Pilling
*University of Birmingham/Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew D. Hislop
*University of Birmingham/Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lijun Wu
†Millennium Pharmaceuticals, Cambridge, MA 02139; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arne N. Akbar
‡Department of Clinical Immunology, Royal Free Hospital, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher D. Buckley
*University of Birmingham/Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul A. H. Moss
*University of Birmingham/Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David H. Adams
*University of Birmingham/Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan B. Rickinson
*University of Birmingham/Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mike Salmon
*University of Birmingham/Medical Research Council Centre for Immune Regulation, University of Birmingham, Birmingham, United Kingdom;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Tetramer-binding CD8+ T cells appear in the CD45RA+ population following Ag exposure and increase in number over time. PBMC from EBV-seronegative subjects and EBV-associated IM patients were assessed by four-color flow cytometry to determine the frequency of EBV Ag-specific cells. Cells were stained with CD3 FITC, PE-conjugated tetramer, CD8 ECD, and CD45RA PE-Cy5. All panels shown are gated on CD3+CD8+ cells. a, EBV-seronegative HLA-B8 individuals show very low levels of RAK-B8 tetramer binding, exclusively within the CD45RA+ population. Data shown is from one of four individuals tested. b, A patient with EBV-associated IM assessed at diagnosis (<1 mo after infection) showed substantial binding of the RAK-B8 tetramer, predominantly in the CD45RO+ population. c, The same patient shown in b assessed after resolution of disease, 12 mo after diagnosis. A marked shift of tetramer-positive cells to the CD45RA+/CD45RO− population was observed. d, Summary of the proportion of tetramer-binding cells within the CD3+CD8+CD45RA+ population during acute disease (at diagnosis) and the memory phase (12 mo after resolution of symptoms). A similar shift toward the CD45RA+ population was seen in nine individuals with EBV-associated IM studied using three EBV tetramers (GLC-A2, YVL-A2, RAK-B8). e and f, Relative expression of CD45RA and CD45RO isoforms by RAK-B8 tetramer binding cells from a single patient at diagnosis (e) and at 12 mo (f).

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    CD8+CD45RA+ tetramer-binding cells express high levels of LFA-1. PBMC from an HLA-A2/B8 individual seropositive for EBV were screened by four-color flow cytometry to assess the phenotype of RAK-B8 tetramer-binding T cells. Cells were stained with a panel of surface marker Abs on FITC, tetramer PE, CD8 ECD, and CD45RA PE-Cy5. Cells were gated to determine the expression of each marker in the indicated populations. Filled areas of histograms indicate the higher-expressing population where a biphasic distribution was observed within the CD8+CD45RA+ population. Both CD11a and CD18 (the α- and β-chains of LFA-1, respectively) showed an absolute relationship with tetramer-binding cells. These results were consistent in 18 individuals tested using EBV tetramers GLC-A2, YVL-A2, and RAK-B8 or CMV tetramers NLV-A2 and TPR-B7.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    Stability of the CD8+CD45RA+LFA-1high phenotype on tetramer-bearing cells. a, Cryopreserved PBMC samples from adult patients with EBV-associated IM collected at intervals after infection were stained using CD11a FITC, tetramer PE, CD8 ECD, and CD45RA PE-Cy5 for four-color flow cytometry. The expression of CD11a was examined in the indicated cell populations. All tetramer-binding cells were in the high level population of CD11a expression at diagnosis and 1 and 10 years after infection. Results are from one HLA-B8 individual using RAK-B8 tetramer and are representative of three individuals tested. Filled areas of histograms indicate the CD11ahigh population. Results for CD18 expression were identical with those for CD11a in each case. b, T cells isolated from umbilical veins were stained using CD11a FITC, CD8 ECD, and CD45RA PE-Cy5. The CD8+CD45RA+ fraction showed no cells with high-level expression of CD11a or CD18. Filled areas of histograms indicate the CD11ahigh population. Representative of three subjects. c, Purified adult CD8+ T cell subsets (>95% purity) and whole cord blood mononuclear cells were labeled with a PNA probe specific for telomere repeat sequences and analyzed by flow cytomery. PNA fluorescence in adult CD8+CD45RA+CD11ahigh cells was significantly less intense than in the CD8+CD45RA+CD11alow cells but was indistinguishable from primed CD8+CD45RO+ cells. Data are representative of three experiments.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Chemokine receptor expression by CD8+ T cell subsets. PBMC from healthy adults were stained for flow cytometry with a panel of antichemokine receptor Abs labeled with FITC, CD11a PE, CD8 ECD, and CD45RA PE-Cy5. Expression of chemokine receptors was examined in CD8+CD45RA+CD11ahigh, CD8+CD45RA+CD11alow, and CD8+CD45RO+ cells. Expression of chemokine receptors by CD45RA+CD11ahigh memory cells closely paralleled that of primed rather than naive CD8+ (CD45RA+CD11alow) cells. Representative of five experiments.

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Comparison of chemokine receptor expression by tetramer-binding CD45RA+ T cells and CD45RA+CD11ahigh cells. PBMC from EBV-seropositive subjects were screened for chemokine receptor expression as described in Fig. 4. In parallel experiments, CD11a PE was replaced by the appropriate PE tetramer. Tetramer-binding CD8+CD45RA+ T cells show the same profile of chemokine receptor expression as CD8+CD45RA+CD11ahigh cells. Representative of three experiments.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    CD8+CD45RA+ memory cells migrate similarly to primed T cells. a, PBL from adult donors were depleted of adherent cells by culture on human serum-coated plates and enriched for CD8+ lymphocytes (60–80% CD8+) by immunomagnetic bead depletion using the Ab cocktail described in Materials and Methods. Overnight migration through 6.5-mm diameter, 5.0-μm Transwells was measured in the presence and absence of chemokines. Cells were resuspended from the Transwell chambers, accurately counted by flow cytometry, and phenotyped by staining with CD11a FITC, CD45RA PE, and CD8 Tricolor. Specific migration of the indicated cell populations was determined by subtracting the values obtained in the absence of chemokine. In vitro migration of CD45RA+CD11ahigh memory cells closely paralleled that of primed rather than naive CD8+ cells. Mean ± SD of three experiments. b, Cells freshly isolated from blood, lymph node, and liver tissue of a single individual were stained with CCR7 FITC, CD11a PE, CD8 ECD, and CD45RA PE-Cy5 for four-color flow cytometry to determine the distribution of CD8+CD45RA+ subpopulations. All histograms were gated to include only CD8+CD45RA+ cells. The reciprocal distribution of CD11a and CCR7 most effectively discriminates naive CD8+CD45RA+CD11alow cells from memory CD8+CD45RA+CD11ahigh cells. One of eight individuals tested.

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    Functional characteristics of CD8+ T cells subsets. a, Freshly isolated PBMC from adult donors were surface stained with CD11a PE, CD8 ECD, and CD45RA PE-Cy5, fixed, and subsequently stained for the indicated intracellular markers. Cell cycle characteristics (Ki-67) or constitutive expression of perforin, Bcl-2, and Bcl-xL were determined in CD8+CD45RA+CD11ahigh, CD8+CD45RA+CD11alow, and CD8+CD45RO+ cells by flow cytometry. Representative of five experiments. b, CD8+CD45RA+ and CD8+CD45RO+ cells were purified by negative selection with magnetic beads and stained with CD11a biotin/streptavidin RED670. Both populations were cultured for 6 h in PMA/Ca+ ionophore with brefeldin A added after 1 h. Cells were permeafixed and stained for intracellular cytokine expression. Production of IL-2 and IFN-γ by CD8+CD45RA+CD11ahigh, CD8+CD45RA+CD11alow, and CD8+CD45RO+ cells was determined by flow cytometry. Representative of five experiments.

PreviousNext
Back to top

In this issue

The Journal of Immunology: 167 (1)
The Journal of Immunology
Vol. 167, Issue 1
1 Jul 2001
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Memory T Cells Constitute a Subset of the Human CD8+CD45RA+ Pool with Distinct Phenotypic and Migratory Characteristics
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Memory T Cells Constitute a Subset of the Human CD8+CD45RA+ Pool with Distinct Phenotypic and Migratory Characteristics
Jeffery M. Faint, Nicola E. Annels, S. John Curnow, Philip Shields, Darrell Pilling, Andrew D. Hislop, Lijun Wu, Arne N. Akbar, Christopher D. Buckley, Paul A. H. Moss, David H. Adams, Alan B. Rickinson, Mike Salmon
The Journal of Immunology July 1, 2001, 167 (1) 212-220; DOI: 10.4049/jimmunol.167.1.212

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Memory T Cells Constitute a Subset of the Human CD8+CD45RA+ Pool with Distinct Phenotypic and Migratory Characteristics
Jeffery M. Faint, Nicola E. Annels, S. John Curnow, Philip Shields, Darrell Pilling, Andrew D. Hislop, Lijun Wu, Arne N. Akbar, Christopher D. Buckley, Paul A. H. Moss, David H. Adams, Alan B. Rickinson, Mike Salmon
The Journal of Immunology July 1, 2001, 167 (1) 212-220; DOI: 10.4049/jimmunol.167.1.212
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
  • Regulatory Roles of IL-2 and IL-4 in H4/Inducible Costimulator Expression on Activated CD4+ T Cells During Th Cell Development
  • Induction of CD4+ T Cell Apoptosis as a Consequence of Impaired Cytoskeletal Rearrangement in UVB-Irradiated Dendritic Cells
Show more CELLULAR IMMUNOLOGY AND IMMUNE REGULATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606